190 related articles for article (PubMed ID: 19567495)
1. Sputum desmosine during hospital admission for pulmonary exacerbation in cystic fibrosis.
Laguna TA; Wagner BD; Luckey HK; Mann SA; Sagel SD; Regelmann W; Accurso FJ
Chest; 2009 Dec; 136(6):1561-1568. PubMed ID: 19567495
[TBL] [Abstract][Full Text] [Related]
2. Urinary desmosine: a biomarker of structural lung injury during CF pulmonary exacerbation.
Laguna TA; Wagner BD; Starcher B; Luckey Tarro HK; Mann SA; Sagel SD; Accurso FJ
Pediatr Pulmonol; 2012 Sep; 47(9):856-63. PubMed ID: 22431382
[TBL] [Abstract][Full Text] [Related]
3. Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis.
Laguna TA; Williams CB; Brandy KR; Welchlin-Bradford C; Moen CE; Reilly CS; Wendt CH
J Cyst Fibros; 2015 May; 14(3):334-40. PubMed ID: 25456770
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis.
Chalmers JD; Moffitt KL; Suarez-Cuartin G; Sibila O; Finch S; Furrie E; Dicker A; Wrobel K; Elborn JS; Walker B; Martin SL; Marshall SE; Huang JT; Fardon TC
Am J Respir Crit Care Med; 2017 May; 195(10):1384-1393. PubMed ID: 27911604
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil elastase correlates with increased sphingolipid content in cystic fibrosis sputum.
Karandashova S; Kummarapurugu A; Zheng S; Kang L; Sun S; Rubin BK; Voynow JA
Pediatr Pulmonol; 2018 Jul; 53(7):872-880. PubMed ID: 29624923
[TBL] [Abstract][Full Text] [Related]
6. Association between pulmonary function and sputum biomarkers in cystic fibrosis.
Mayer-Hamblett N; Aitken ML; Accurso FJ; Kronmal RA; Konstan MW; Burns JL; Sagel SD; Ramsey BW
Am J Respir Crit Care Med; 2007 Apr; 175(8):822-8. PubMed ID: 17234902
[TBL] [Abstract][Full Text] [Related]
7. Extracellular DNA in sputum is associated with pulmonary function and hospitalization in patients with cystic fibrosis.
Piva TC; Luft C; Antunes KH; Marostica PJC; Pinto LA; Donadio MVF
Respir Med; 2020 Oct; 172():106144. PubMed ID: 32937222
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects.
Sloane AJ; Lindner RA; Prasad SS; Sebastian LT; Pedersen SK; Robinson M; Bye PT; Nielson DW; Harry JL
Am J Respir Crit Care Med; 2005 Dec; 172(11):1416-26. PubMed ID: 16166615
[TBL] [Abstract][Full Text] [Related]
9. SPLUNC1 as a biomarker of pulmonary exacerbations in children with cystic fibrosis.
Ben-Meir E; Perrem L; Shaw M; Ratjen F; Grasemann H
J Cyst Fibros; 2024 Mar; 23(2):288-292. PubMed ID: 38413298
[TBL] [Abstract][Full Text] [Related]
10. Chronic bacterial pulmonary infections in advanced cystic fibrosis differently affect the level of sputum neutrophil elastase, IL-8 and IL-6.
Majka G; Mazurek H; Strus M; Ciszek-Lenda M; Szatanek R; Pac A; Golińska E; Marcinkiewicz J
Clin Exp Immunol; 2021 Sep; 205(3):391-405. PubMed ID: 34031873
[TBL] [Abstract][Full Text] [Related]
11. Sputum glucose and glycemic control in cystic fibrosis-related diabetes: a cross-sectional study.
Van Sambeek L; Cowley ES; Newman DK; Kato R
PLoS One; 2015; 10(3):e0119938. PubMed ID: 25803537
[TBL] [Abstract][Full Text] [Related]
12. Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity.
Hair PS; Sass LA; Vazifedan T; Shah TA; Krishna NK; Cunnion KM
PLoS One; 2017; 12(3):e0173257. PubMed ID: 28278205
[TBL] [Abstract][Full Text] [Related]
13. Inhalation of LPS induces inflammatory airway responses mimicking characteristics of chronic obstructive pulmonary disease.
Korsgren M; Linden M; Entwistle N; Cook J; Wollmer P; Andersson M; Larsson B; Greiff L
Clin Physiol Funct Imaging; 2012 Jan; 32(1):71-9. PubMed ID: 22152082
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, safety and effect on biomarkers of AZD9668 in cystic fibrosis.
Elborn JS; Perrett J; Forsman-Semb K; Marks-Konczalik J; Gunawardena K; Entwistle N
Eur Respir J; 2012 Oct; 40(4):969-76. PubMed ID: 22267768
[TBL] [Abstract][Full Text] [Related]
15. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis.
Eickmeier O; Fussbroich D; Mueller K; Serve F; Smaczny C; Zielen S; Schubert R
PLoS One; 2017; 12(2):e0171249. PubMed ID: 28158236
[TBL] [Abstract][Full Text] [Related]
16. Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia.
Ratjen F; Waters V; Klingel M; McDonald N; Dell S; Leahy TR; Yau Y; Grasemann H
Eur Respir J; 2016 Mar; 47(3):829-36. PubMed ID: 26585432
[TBL] [Abstract][Full Text] [Related]
17. The expression of Mirc1/Mir17-92 cluster in sputum samples correlates with pulmonary exacerbations in cystic fibrosis patients.
Krause K; Kopp BT; Tazi MF; Caution K; Hamilton K; Badr A; Shrestha C; Tumin D; Hayes D; Robledo-Avila F; Hall-Stoodley L; Klamer BG; Zhang X; Partida-Sanchez S; Parinandi NL; Kirkby SE; Dakhlallah D; McCoy KS; Cormet-Boyaka E; Amer AO
J Cyst Fibros; 2018 Jul; 17(4):454-461. PubMed ID: 29241629
[TBL] [Abstract][Full Text] [Related]
18. Expression of soluble triggering receptor expressed on myeloid cells-1 in childhood CF and non-CF bronchiectasis.
Masekela R; Anderson R; de Boeck K; Vreys M; Steel HC; Olurunju S; Green RJ
Pediatr Pulmonol; 2015 Apr; 50(4):333-9. PubMed ID: 25348906
[TBL] [Abstract][Full Text] [Related]
19. Resistin is elevated in cystic fibrosis sputum and correlates negatively with lung function.
Forrest OA; Chopyk DM; Gernez Y; Brown MR; Conrad CK; Moss RB; Tangpricha V; Peng L; Tirouvanziam R
J Cyst Fibros; 2019 Jan; 18(1):64-70. PubMed ID: 29937317
[TBL] [Abstract][Full Text] [Related]
20. Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis.
Dittrich AS; Kühbandner I; Gehrig S; Rickert-Zacharias V; Twigg M; Wege S; Taggart CC; Herth F; Schultz C; Mall MA
Eur Respir J; 2018 Mar; 51(3):. PubMed ID: 29545279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]